About repa glini de
Meglitinide blood glucose-lowering medicine
Used for
- Helps control blood sugar in adults with type 2 diabetes, alongside diet and exercise.
Usual adult dose
Usually 0.5–4 mg before each main meal; maximum 16 mg daily. Dose is adjusted to blood sugar levels.
Common side effects
- Low blood sugar
- Weight gain
- Stomach discomfort or diarrhoea
- Headache
Important warnings
- Skip the dose if skipping a meal.
- Not for type 1 diabetes or diabetic ketoacidosis.
- Use caution with liver problems; low blood sugar risk increases with missed meals or alcohol.
- Can cause severe low blood sugar, especially with other diabetes medicines.
Pregnancy
Use during pregnancy is generally avoided; insulin is usually preferred for diabetes management.
Breastfeeding
Breastfeeding is generally not recommended while taking repaglinide because infant safety is uncertain.
Interactions
- Gemfibrozil can greatly increase repaglinide levels; combination is contraindicated.
- Clarithromycin, cyclosporine, and azole antifungals can increase its effects.
- Rifampicin and carbamazepine may reduce its effects.
- Other diabetes medicines can increase low blood sugar risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.